Mike Washburn Email & Phone Number
@gsk.com
1 phone found area 208
LinkedIn matched
Who is Mike Washburn? Overview
A concise factual answer block for searchers comparing this professional profile.
Mike Washburn is listed as Executive Director, Head of Integrative Sciences, Oncology Translational Medicine at GSK, a with 90451 employees, based in Greater Philadelphia, United States. AeroLeads shows a work email signal at gsk.com, phone signal with area code 208, and a matched LinkedIn profile for Mike Washburn.
Mike Washburn previously worked as Executive Director, Head of Precision Medicine Data & Analytics at Gsk and Head of Reverse Translation & Innovation at Gsk. Mike Washburn holds Doctor Of Philosophy (Ph.D.) from University Of North Carolina At Chapel Hill.
Email format at GSK
This section adds company-level context without repeating Mike Washburn's masked contact details.
AeroLeads found 2 current-domain work email signals for Mike Washburn. Compare company email patterns before reaching out.
About Mike Washburn
As the Executive Director and Head of Precision Medicine Data & Analytics at GSK, I have over 13 years of pharma experience leading translational, biomarker, innovation and data analytics teams across oncology, infectious disease, respiratory and immunology therapeutic areas. I have a strong track record of leading precision medicine strategies through clinical development and successful regulatory approval. I am passionate about leveraging advanced data analytics to discover mechanisms linked to improved outcomes and apply them to clinical development strategies that will support patient monitoring, selection and advancing the science of precision medicine.
Listed skills include Drug Discovery, Molecular Biology, Immunology, Animal Models, and 13 others.
Mike Washburn's current company
Company context helps verify the profile and gives searchers a useful next step.
Mike Washburn work experience
A career timeline built from the work history available for this profile.
Executive Director, Head Of Precision Medicine Data & Analytics
Current
Head Of Reverse Translation & Innovation
Leading Reverse Translation & Innovation within GSK oncology, technology & innovation priorities, business development biomarker and translational strategic leadership.
Group Senior Director, Head Of Immuno-Oncology Biomarkers, Gsk Fellow.
Head of Immuno-Oncology Biomarkers in the oncology Experimental Medicine Unit responsible for delivering translational and experimental medicine approaches to progress novel immuno-oncology, cell therapy, and molecular targeted therapies from early clinical trials through registration. Leader of Microbiome Innovation and Clinical Imaging teams discovering mechanisms linked to improved outcomes that will support patient monitoring and/or selection.
Clinical Biomarker Leader, Gsk Fellow
Biomarker leader for novel immuno-oncology combination clinical programs
Senior Scientific Investigator, Gsk Fellow
● Program leader for a novel immunology target to treat infectious diseases and immune disorders.● Clinical biomarker strategy leader● Translational group leader
Investigator. Infectious Diseases, Medicines Discovery & Development
● Program leader for a novel immunology target to treat infectious diseases.● Translational in vivo group leader - Designed, coordinated and executed over 30 large scale efficacy and model characterization studies that provided go/no go decisions for multiple targets - Established partnerships with several CRO’s and academic labs to leverage expertise and quickly produce key decision making results. ● Developed a clinical biomarker strategy to evaluate the association between immuno-inflammatory changes, pharmacodynamics/pharmacokinetics, and the clinical response to a novel therapeutic treatment.● Collaborated with external institutions to investigate human genetic and host transcriptomic changes that are linked to disease severity and susceptibility for infectious diseases. This work may lead to novel targets, better defined objective clinical endpoints, and enrichment of patient populations that are more likely to respond to therapy.● Achieved endorsement of strategy for novel approaches to treat infectious diseases.● Conceived and led early projects to identify and validate novel therapeutic targets.● Contributed to clinical study protocol development and regulatory submissions
Principal Scientist. Infectious Diseases, Medicines Discovery & Development
● Immunologist and animal model group leader of the HCV biology drug discovery team involved in target validation, mechanism of action, and candidate selection of novel anti-viral drugs. ● Optimized and validated disease relevant in vivo and in vitro models of HCV infection. ● Delivered novel ideas and targets into testable hypothesis for the development of immunotherapies for the treatment of HCV. ● Identified and helped develop novel targets for the treatment of liver fibrosis
Postdoctoral Fellow
Ph.D. In Genetics And Molecular Biology/ Viral Immunology
My research focused the development and characterization of an improved humanized mouse model designed to study human hepato-tropic viruses and their interaction with both the human immune system and liver. I showed that the mice are susceptible to HCV infection and develop human immune responses to the virus, leading to liver fibrosis. Another project focused on utilizing the LIGHT protein as an immunotherapy to clear persistent viral infections from the liver.
Research Technician At The Gene Therapy Center
I developed and validated novel and safer Adeno-Associated Virus (AAV) vectors that have the potential to be used in human gene therapy clinical trials.
Research Assistant
I identified and classified spore coat proteins in Bacillus subtilis and Bacillus anthracis using 2-D gel electrophoresis technology.
Research Assistant
I discovered novel protein interactions among Drosophila cell cycle regulators using Yeast Two-Hybrid IST technology.
Mike Washburn education
Doctor Of Philosophy (Ph.D.)
B.S., Microbiology
Frequently asked questions about Mike Washburn
Quick answers generated from the profile data available on this page.
What company does Mike Washburn work for?
Mike Washburn works for GSK.
What is Mike Washburn's role at GSK?
Mike Washburn is listed as Executive Director, Head of Integrative Sciences, Oncology Translational Medicine at GSK.
What is Mike Washburn's email address?
AeroLeads has found 2 work email signals at @gsk.com for Mike Washburn at GSK.
What is Mike Washburn's phone number?
AeroLeads has found 1 phone signal(s) with area code 208 for Mike Washburn at GSK.
Where is Mike Washburn based?
Mike Washburn is based in Greater Philadelphia, United States while working with GSK.
What companies has Mike Washburn worked for?
Mike Washburn has worked for Gsk, University Of North Carolina At Chapel Hill, University Of Michigan, and Wayne State University School Of Medicine.
Who are Mike Washburn's colleagues at GSK?
Mike Washburn's colleagues at GSK include Arpit Dixit.
How can I contact Mike Washburn?
You can use AeroLeads to view verified contact signals for Mike Washburn at GSK, including work email, phone, and LinkedIn data when available.
What schools did Mike Washburn attend?
Mike Washburn holds Doctor Of Philosophy (Ph.D.) from University Of North Carolina At Chapel Hill.
What skills is Mike Washburn known for?
Mike Washburn is listed with skills including Drug Discovery, Molecular Biology, Immunology, Animal Models, In Vitro, In Vivo, Infectious Diseases, and Clinical Trials.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial